Assessment of the incidence of neonatal sepsis, its risk factors, antimicrobials use and clinical outcomes in Bishoftu General Hospital, neonatal intensive care unit, Debrezeit-Ethiopia

Minyahil Alebachew Woldu, Molla Belay Guta, Jimma Likisa Lenjisa, Gobezie Temesgen Tegegne, Gurmu Tesafye, Hunduma Dinsa


Background: The incidence of neonatal sepsis (NS) varies from 6 to 9 cases per 1000 live births, but is higher among low-birth-weight neonates. Therefore, the purpose of this study was to examine the risk factors, antimicrobial use pattern and clinical outcomes of NS at Bishoftu General Hospital, neonatal intensive care unit, Debrezeit-Ethiopia.

Methods: A prospective cross-sectional study was conducted using pretested and validated checklists.

Results: Among the total 306 neonates (0-28 days of age) recruited, 249 (81.4%) were age ≤7 days, 169 (55.23%) were male, 251 (82%) were attended antenatal care, 136 (44.44%) were low in birth weight (≤2.5 kg) and 155 (50.7%) had total of white blood cell count ≥12000/mm3. 221 (72.2%) of the neonates diagnosed as sepsis received antibiotics while 74 (24.2%) received antibiotics for other diagnosis. The most frequently prescribed antibiotic was the combination of ‘ampicillin + gentamicin’ prescription 67 (21.9%) followed by the single antibiotic prescriptions of benzyl penicillin 33 (10.8%) and cloxacillin 8 (2.6%). A significant number of neonates (p = 0.000) with 95% confidence interval of (1.934-8.967) were born in health center and developed sepsis. This value is 4.2 times higher when compared with the neonates born in the home. A significant number of neonates using instrument in hospitals were also developed sepsis (p = 0.26). The risk of acquiring sepsis in neonates born using instrument was almost 6.2 times more common than children born vaginal in the natural way. A significant number of neonates born from mothers’ with urinary tract infections (UTI) developed sepsis (p = 0.02) and this figure was almost 2.9 times higher compared to neonates born from mothers’ with no UTI diagnosis.

Conclusions: In the present study, the most common risk factors were identified and place of delivery, mode of delivery and mother with UTI during delivery were the most common risk factors for the incidence of NS.


Neonatal sepsis, Neonatal antimicrobial use pattern, Neonatal sepsis risk factors

Full Text:



Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2-8.

Gupta P, Murali MV, Faridi MM, Kaul PB, Ramachandran VG, Talwar V. Clinical profile of klebsiella septicemia in neonates. Indian J Pediatr. 1993;60(4):565-72.

Dawodu A, Al Umran K, Twum Danso K. A case study of neonatal sepsis in very low birth weight infants. N Engl J Med. 2002;347:240-7.

Motara F, Ballot DE, Perovic O. Epidemiology of neonatal sepsis at Johannesburg Hospital. South Afr J Epidemiol Infect. 2005;20:90-3.

Kraus DM, Pham JT. Neonatal therapy. In: Koda-Kimble MA, Yee YL, Alldredge BK, Kradjan WA, Guglielmo BJ, Corelli RL, editors. Applied Therapeutics: The Clinical Use of Drugs. 9th Edition. Philadelphia: Lippincott Williams & Wilkins; 2009.

Kaftan H, Kinney JS. Early onset neonatal bacterial infections. Semin Perinatol. 1998;22(1):15-24.

Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr. 1996;129(1):63 71.

Serious infections in young infants in developing countries: rationale for a multicenter study. The WHO Young Infants Study Group. Pediatr Infect Dis J. 1999;18 10 Suppl:S4-7.

World Health Organization. Prenatal mortality. Geneva: WHO; 1996.

Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG. Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis. 2007;7(5):358-68.

Newman MJ, Frimpong E, Asamoah-Adu A, Sampane-Donkor E. Resistance to antimicrobial drugs in Ghanaian-Dutch Collaboration for Health Research and Development; 2006.

Chacko B, Sohi I. Early onset neonatal sepsis. Indian J Pediatr. 2005;72(1):23-6.

Dhumal P, Ujagare M, Gandham N, Nagdawane RP, Sardar M, Sharma M, et al. Incidence and antimicrobial susceptibility pattern of neonatal septicaemia from tertiary care hospital of India. Int J Med Clin Res. 2012;3(7):207-11.

Demissie S, Lulsesed S. Neonatal sepsis: bacterial etiologic agents and their antibiotic susceptibility pattern in Tikur Ambessa University Hospital, Addis Abeba, Ethiopia. Ethiop J Pediatr Child Health. 2009;5(5):5-16.

Weston EJ, Pondo T, Lewis MM, Martell-Cleary P, Morin C, Jewell B, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J. 2011;30(11):


Mukhopadhyay S, Puopolo KM. Risk assessment in neonatal early onset sepsis. Semin Perinatol. 2012;36(6):408-15.

Ogunlesi TA, Ogunfowora OB. Predictors of mortality in neonatal septicemia in an underresourced setting. J Natl Med Assoc. 2010;102:915-21.

Jumah DS, Hassan MK. Predictors of mortality outcome in neonatal sepsis. Med J Basrah Univ (MJBU). 2007;25(1):11-8.

Vergnano S, Sharland M, Kazembe P, Mwansambo C, Heath PT. Neonatal sepsis: an international perspective. Arch Dis Child Fetal Neonatal Ed. 2005;90(3):F220-4.

Caserta MT. Neonatal Sepsis. The Merk Mannual; 2013.